Chatswood serves the life and health insurance sector in New Zealand with market intelligence, data, and bespoke consulting services. Some of these are provided in conjunction with Quality Product Research Limited - a subsidiary that brings you Quotemonster.
We believe that good decisions are more likely to occur when we have good information about the market environment in which we operate. Intuitive leaps and creative decisions are always required, of course, but the more they are based on a firm foundation of observation, the better they tend to be.
FSC Life and Health Insurance Special Interest Group Networking Event and launch of Money and You research
The FSC will be exploring trends and insights from their latest Money and You research report ‘'Protecting Possessions, Not People' at the upcoming Life and Health Insurance Special Interest Group Networking Event in July.
The Financial Services Council (FSC) will be exploring trends and insights from their latest Money and You research report ‘'Protecting Possessions, Not People' at the upcoming Life and Health Insurance Special Interest Group Networking Event in July. The event is open to FSC members in the Life and Health insurance community and will feature:
The value of Fringe Benefit Tax exemptions for health insurers with insights from the NZIER investigation, presented by Tony Reid from Southern Cross.
Genetic testing - examples of the impacts of banning the use of genetic testing in underwriting, presented by Stephen Potter from AIA New Zealand.
Outlining good practice for informing future MBIE consultations with Kirk Hope, CEO of the Financial Services Council.
Money and You: Protecting Possessions, Not People Research Launch - a taster of the FSC’s newest research with FSC Research Committee Chair, Mark Banicevich and a small panel discussion on the attitudes of New Zealanders and insurance.
The event will run from 10:30am – 12:30pm on 15 July at Russell McVeagh, Level 30, Vero Centre, 48 Shortland Street, Auckland Central, or people can join online, you can register here.
Munich Re look at how insurers can develop prevention strategies
Prevention is all about intervening before a disease or condition occurs – trying to extend the health span of peoples’ lives and prevent claims from arising in the first place. Munich Re’s Life Science Report looks at prevention strategies insurers can implement.
Munich Re’s Life Science Report 2025 has insights on global trends and risks that will shape the insurance industry over the next decade. We’ve written about their in-depth looks at AI in Healthcare and Improving Cancer Outcomes sections, and now we’re looking at their Prevention chapter.
Prevention is all about intervening before a disease or condition occurs – trying to extend the health span of peoples’ lives and prevent claims from arising in the first place.
In order to develop effective preventative strategies, insurers need a deep understanding of each of their clients’ unique characteristics, risk factors and health trends. Insurers should focus on areas where they’ll get the most bang for their buck, addressing lifestyle factors that contribute to the most significant preventable health risks and claims drivers – namely cardiovascular disease, cancer and mental health conditions. The key preventable causes for these are obesity, unhealthy diet, physical inactivity, smoking, excessive drinking and poor sleep patterns. Munich Re have a range of tables showing the impact of preventive measures on mortality, disability, critical illness and health care costs.
Munich Re categorise preventative health measures based on the stages of disease they are intended to prevent:
Primordial prevention - preventing development of risk factors for the entire population
Primary prevention - prevent onset of disease e.g. through lifestyle adjustments and medications
Secondary prevention - early diagnosis (e.g. through screening programmes) and prompt treatment
Tertiary prevention - manage existing disease to minimise complications and improve outcomes to prevent further morbidity and mortality
Quaternary prevention - protect from medical interventions that are likely to cause more harm than good.
To be effective, targeted interventions need to address an individual’s unique needs. By using personalised risk profiling, digital risk scores and advanced analytics, insurers can tailor interventions to maximise impact. To be efficient, insurers need to be able to amplify their prevention efforts to reach a wide audience and use digital systems to automate processes and incorporate real-time feedback. One of the most effective means of prevention is improving health literacy, the ability to navigate health information and make informed decisions. Munich Re suggest that informing policyholders about prevention benefits, enhancing health literacy, making things easy and incentivising members will all help drive positive health outcomes.
As we’ve already seen starting to occur here in NZ, insurers are positioning themselves as active participants in the well-being of their policyholders (with AIA’s Vitality programme perhaps the most notable example of this). We’d love to hear from you instances where your clients health insurance has led to them taking proactive steps to improve their health.
More news:
AIA employees return to newly renovated office space at AIA House in Smales Farm
AIA launch the third edition of Hikitia Mai, their Women in Leadership programme
Legal and regulatory update for the life and health insurance sector
FMA operational budget increases; Minister of Commerce and Consumer Affairs April diary released; FMA release Good Cents: Kiwis on savings and debt research.
25 May 2025 - The FMA operational allocation rose from about $71.3 million in the previous fiscal year to almost $78 million for the 2025/26 budget period. https://investmentnews.co.nz/investment-news/fma-wins-6-7m-pay-rise-on-compliance-enforcement-upgrades/
28 May 2025 - Minister of Commerce and Consumer Affairs, Hon Scott Simpson, April 2025 diary released with the following potential financial services sector related meetings noted:
2 Apr 2025 – MEET: Kiwibank (Steve Juravich)
3 Apr 2025 – MEET: Financial Ombudsman (Susan Taylor, Jane Meares)
3 Apr 2025 – MEET: Commerce Commission Review Panel (Paula Rebstock,Allan Fels, David Hunt)
3 Apr 2025 – MEET: Chair of ACC Board (Dr Tracey Batten)
7 Apr 2025 - ATTEND: Financial Services Council Roundtable (invited guests)
8 Apr 2025 – MEET: ACC Board (ACC Board)
10 Apr 2025 – MEET: FMA (Samantha Barrass)
14 Apr 2025 -MEET: Commerce Commission (Commerce Commission)
15 Apr 2025 – MEET: ACC Officials (ACC, MBIE, Treasury Officials)
15 Apr 2025 – MEET: MBIE Officials (MBIE Officials)
17 Apr 2025 – MEET: Chair & CE of ACC (Dr Tracey Batten & Megan Main)
23 Apr 2025 -MEET: MBIE Officials (MBIE Officials)
29 Apr 2025 – SPEAK: Financial Services Leaders Roundtable (Invited Guests)
29 Apr 2025 – MEET: ACC Board Chair (Dr Tracey Batten)
30 Apr 2025 – MEET: AIA (Nick Stanhope)
29 May 2025 - The FMA releases Good Cents: Kiwis on savings and debt research, which looks into New Zealanders' attitudes and behaviours towards savings, debt reduction, and financial guidance. https://www.fma.govt.nz/news/all-releases/media-releases/good-cents-kiwis-on-savings-and-debt-research/
Best product, no. Best solution, yes!
Steve Wright questions what makes the best product in his latest article on Good Returns.
We are in enthusiastic agreement with Steve Wright’s recent article, in which he questions what makes the best product in his latest article on Good Returns. Steve advocates that the FMA and Disputes Resolution Service need to debunk the view of advisers that they sell only the ‘best’ product as rated by independent services.
As a research business, we are happy to debunk the notion that we tell people what to sell, or ‘rank’ products. We go to great pains to point out that this is not our job, we understand that our role is to provide useful information about the meaningful differences between products to enable advisers to have better conversations about suitability. We will never tell you what product to recommend because only financial advisers can give financial advice. To quote directly from a slide from our recent roadshow:
We also highlighted the importance of recognising the financial adviser’s unique role in the process of reconciling objectives with options and choices and limitations to arrive at a good solution, which is nearly always a compromise, unique to the client. That’s the essence of suitability assessment, entirely within the financial adviser’s legally defined role. If you haven’t heard us talk through the leading car purchase example, join us at a training session coming soon!
Like Steve, we believe that the best product is the one that suits the specific clients’ needs – even if it’s not the most generous, or the highest rated. He stresses that advisers must thoroughly understand a client’s individual circumstances, risks, and goals to come up with the most suitable product, then give enough detail that the clients can understand the advice and the products recommended.
What are some examples you’ve come across of products that at first look may not be the ‘best’, but actually have been the best fit for your clients?
If you have missed some of the comments on Steve’s article, we particularly like these:
“Advisers must give financial advice that I'd suitable… suitability has a lot more to do with the client circumstances than stars”
“In short, I don’t believe that we should be looking for who’s the “best.” I believe we should be looking for the “best fit.” And that’s a very different thing!”
“It's a good discussion point, but if you want a more realistic glimpse of what is likely to happen here in the future, speak to those involved in the Australian market about the removal of the 'safe harbour' provision in their financial advice regulation. Not only is it likely that product research into features and benefits likely to become more necessary, not less, but it also seems more and more likely that the actual underwriting terms offered across the entire market will need to be considered.”
More news:
Financial Advice NZ upcoming webinars and workshops - Data Informed Decisions & Demonstrating Suitability of Advice for Private Health Insurance 28 May, Navigating the Complexities of a Blended Family 11 June, Ethics Workshop 12 June, Understanding Portfolio Investment Entities (PIE’s) 25 June, Tackling the Tough Questions 25 June
Apex Advice partners with Pathfinder to expand ethical KiwiSaver investment options
The Co-operative Bank comes top in customer satisfaction survey
Munich Re look at improving Cancer outcomes
As part of Munich Re’s Life Science Report 2025, they have investigated the projected impact of advances in cancer treatment and research. These advances will change how cancers are defined, prevented, diagnosed and treated and are expected to significantly improve cancer mortality.
As part of Munich Re’s Life Science Report 2025, they have investigated the projected impact of advances in cancer treatment and research. These advances will change how cancers are defined, prevented, diagnosed and treated and are expected to significantly improve cancer mortality.
Cancer is the leading cause of death among policyholders for most insurers worldwide, as such it demands investigation. Much progress has been made in the past couple of decades to improve cancer mortality, through both reducing cancer risk factors (such as the dramatic downturn in tobacco use) and better diagnosis and treatment. Mortality improvement trends are expected to accelerate as our understanding of cancer genetics are combined with artificial intelligence (AI).
AI will be used to both improve cancer risk prevention and diagnostics. AI analysis of an individual’s personal information such as health data, family history, genetic and epigenetic profiles, microbiome, living environment and exposure history, sometimes called a statistical biopsy, will give a better understanding of risk for a wide range of cancers. This could potentially allow for a personalised approach to risks, behaviours, and identification of which strategies may be most effective in addressing these factors.
Being able to diagnose cancer more accurately, and at earlier stages, should improve cancer mortality. AI has already led to refinements in imaging studies, and in blood, urine and tissue samples. AI can also be used to analyse the tumour’s genetic pattern, other associated biomarkers and an individual’s risk profile to allow for better prognosis and management approach. AI’s ability to recognise patters not apparent to humans will help with diagnostic tools such as imaging studies, pathologic specimen interpretation and photograph analysis.
More effective screening approaches will lead to earlier cancer diagnosis and improved cancer mortality. An important technology, ‘liquid biopsy’, is currently used to analyse fluids to look for markers indicating the presence of a cancer, typically used to detect residual cancer after treatment or recurrence. If a liquid biopsy test that can screen for multiple cancers in asymptomatic individuals could be brought to market at a price point where it is accessible to the masses, it would be a game changer. Though it would also raise concerns about over-diagnosis and surveillance bias, as some identified cancers may never post a significant mortality risk.
The combination of AI and genomic analysis of tumour cells and immune cells has led to the development of targeted treatments that exploit specific genetic patterns. These treatments are more precise and safer than chemotherapy, with the four key categories of therapies emerging being targeted monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines and adoptive cell immunotherapy.
With potential changes in how cancers are classified, product definitions will need to be modified. Instead of being classified based on their tissue of origin, it’s expected new cancer tests will be able to categorise cancers based on their underlying genetic causes – potentially leading to thousands of cancer subtypes.
Where previously terminal cancers become able to be managed and instead turn into chronic disease, there may be implications for living benefits products. Reduced mortality should be favourable for life insurances businesses, though the costs of more sophisticated, individualised cancer treatments may have a negative cost impact on health insurance businesses. Munich Re predict that advances in diagnosis and changes in diagnostic criteria are going to increase cancer incidence rates in the short term, but may decrease critical illness rates if major advances in cancer prevention are realised.
AI will also have implications for underwriting. AI-based diagnosis is likely to be more accurate and predictive than current methods, with fewer false positive and false negative results, enabling risk to be better assessed. Better monitoring post-cancer treatment will mean recurrence risk can be more accurately assessed too.
More news:
Southern Cross Health Trust to fund salaries of nursing positions at City Missions
Kiwi advisers believe AI could help improve advice delivery
Pharmac to fund or widen access to three treatments, including for skin cancer, from 1 June 2025
FSC release Financial Resilience Index 2025
The Financial Services Council (FSC) have released their latest Financial Resilience Index 2025. Results find that Kiwi are still feeling the financial pinch.
The Financial Services Council (FSC) have released their latest Financial Resilience Index 2025. Results find that Kiwi are still feeling the financial pinch.
Key findings include:
55% of New Zealanders worry about money daily or weekly
Job security is more of a concern, with 80% of respondents feel secure in their current roles, down from 85% in 2024 and 89% in 2023
Only 44% feel financially prepared for retirement, down from 50% in 2024. 20% feel not at all prepared.
Concerns around inflation, housing prices and interest rates have eased slightly across the board
KiwiSaver remains the top investment New Zealanders have, with 81% of Kiwis enrolled. The next most common investments are cash, including term deposits (40%), NZ shares (23%) and managed funds (17%)
Only 44% feel financially prepared for retirement (down 6%)
Self-reported financial literacy continues its downward trend, with only 43% of respondents considering themselves financially literate
More news:
ICNZ publish their annual report for 2024
New research shows 75% of Kiwi want their money invested according to their values
Legal and regulatory update for the life and health insurance sector
The FMA release #4 of Jess Learns to Invest podcast; FMA announce the six fintech firms will be taking part in the pilot regulatory sandbox; first edition of FMA Financial Advisers Update released; FMA publish a Consumer Confidence Factsheet; FMA release ‘5 mins with the FMA’ podcast #13; Office of the Privacy Commissioner seeks feedback on Privacy Amendment Bill (IPP3A) draft guidance; RBNZ research investigates why the ‘natural interest rate’ has fallen in NZ.
29 Apr 2025 - The FMA release Jess Learns to Invest Episode 4 | Market Volatility and Your Investments with Brad Olsen. https://www.fma.govt.nz/library/podcast/jess-learns-to-invest-episode-4/
29 Apr 2025 - The FMA has announced the six fintech firms who will be testing their innovative products, services or business models in the FMA’s pilot regulatory sandbox.
The successful fintech firms are:
• ECDD Holdings Limited - part of the exchange service Easy Crypto) intends to launch a yield bearing NZD-backed stablecoin and to generate revenue from interest earned on money held on trust in interest-bearing accounts.
• Emerge Group Limited - intending on offering a digital-first business banking alternative for small and medium-sized enterprises (SMEs).
• Homeshare - which appears to be an investment company aiming to assist period with home sharing schemes.
• IndigiShare - with aims to offer a koha-loan platform designed to break down barriers to entry for indigenous businesses and provide funding for Māori entrepreneurs, startups, and SMEs, especially those with a strong social impact
• Invest in Farming Co-op - with intention to offer individuals a way to invest in agricultural businesses directly from their smartphones.
• Tandym Limited - currently offers full-service solutions for recruitment and workforce development and management, connecting businesses with top talent, we are unsure what their interest in financial services.
https://www.fma.govt.nz/news/all-releases/media-releases/fintech-sandbox-participants/
29 Apr 2025 - The FMA has published the first edition of FMA Financial Advisers Update. https://createsend.com/t/r-B06F256588858C182540EF23F30FEDED
29 Apr 2025 - The FMA have published a Consumer Confidence Factsheet. The results of the Consumer Confidence Survey indicate that that Māori and women are less likely like to feel confident in NZ's financial markets, and less likely to feel confident our financial markets are effectively regulated. The results indicate that Māori and women are less likely like to have health or life Insurance, but Māori are more likely to have funeral Insurance. https://www.fma.govt.nz/library/research/consumer-confidence-factsheet-2025/
29 Apr 2025 - The FMA release ‘5 mins with the FMA’ podcast #13: Consumer Confidence Survey. https://www.fma.govt.nz/library/podcast/5-mins-with-the-fma-podcast-13/
30 Apr 2025 - The Office of the Privacy Commissioner is asking for feedback on Privacy Amendment Bill (IPP3A) draft guidance. Feedback can be submitted between 30 April - 25 June 2025. https://www.privacy.org.nz/news/haveyoursay/
1 May 2025 - The RBNZ has released research which investigates why the ‘natural interest rate’ has fallen in New Zealand over recent decades. https://www.rbnz.govt.nz/hub/news/2025/05/research-investigates-why-the-natural-interest-rate-has-fallen-in-new-zealand-over-recent-decades
Partners Life announce new Chief People Officer
Partners Life has announced that Helen Meade has been appointed as their new Chief People Officer, effective April 2025.
Partners Life has announced that Helen Meade has been appointed as their new Chief People Officer, effective April 2025. Most recently Meade was Chief People Officer at Les Mills International and she has over 20 years’ experience in human resources, transformation and communications, having worked in the insurance, wellness/health, technology and FMCG sectors.
Partners Life CEO Michael Weston said
“I'm delighted about Helen joining our executive team. She's a dynamic leader with a proven track record of attracting, developing and retaining great people and teams – who are our most important asset and competitive advantage.”
More news:
Banking Ombudsman Service cases up 3% more than the previous quarter
ICNZ finds 20% had switched insurance providers in the last two years
Quality Product Research: Research Advisory Board – Northern
Last month we held our first Research Advisory Board meeting of the year and got lots of valuable feedback on items ranging from ratings for rural key person to proposed rating of disclosure.
Last month we held our first Research Advisory Board meeting of the year with our Northern Representatives and as usual returned to Quotemonster HQ with lots of valuable feedback.
Board members: Allan Gillbanks (Owner, Director of The Quantum Group) and Katrina Church (Director, Head of Client Engagement of Insurance People)
Independent Chair: Tony Dench
Insurer Observers: Laura Fitzpatrick (Asteron Life)
Research Team: Russell Hutchinson, Doreen Dutt, Sara Alani and Kim Oliver
The research advisory board reviewed the following topics:
Interim Cover: based on discussions, QPR will look to create some educational material on interim cover.
The Addition of Legacy Research to our Standard Quote Flow: for improved clarity, we’ll review renaming ‘Legacy products’ to ‘Closed products’ and look to include a workflow to help advisers handle legacy products.
Specific injury add-on compared to built-in for IP: we will review the value of Specific Injury as a built-in item vs a standalone item.
Finalised Rating for Rural Key Person: we announced the launch of rural key person cover ratings for five providers - AIA, Asteron Life, Fidelity Life, Chubb Life, and Partners Life. Based on discussions, we will review the rating differences for some specific features. We’ll also gather feedback on the weighting for home modifications and vocational rehabilitation to ensure the ratings accurately reflects their value.
The Proposed rating of disclosure: this is all about how easy it is to find policy documents on insurers’ websites and for customers to access all required documentation easily. We plan to review and rate this feature across all products in future.
The Proposed rating of Waiver of Premium: members liked the idea of splitting up the different types of premium waivers and having them as separate items (injury {traditional WOP}, parental leave, unemployment, and redundancy being the main 4 categories). Our research team will look to implement these changes in our database in the next few months.
Quote Functionality - Error Message / Exact Match vs Near Match: we’re looking into whether we’ll be able to implement near matches (rather than just exact matches) for products that are similar but not the same.
As always, the feedback from our Research Advisory Board meetings has been very valuable to our Research team and allows us to strengthen our research ratings by getting more insight into the adviser perspective. We look forward to meeting with our Central and Southern Advisory Boards later in the year.
nib research finds more adults are staying on top of essential health screenings
Recent nib research has found that more adults are staying on top of essential health screenings, but costs remain a barrier.
Recent nib research has found that more adults are staying on top of essential health screenings, but costs remain a barrier. The research was carried out in February 2025 and surveyed 1,010 Kiwi, building on the last survey conducted in December 2023. Some of the key findings include:
An increasing number of adults are keeping up with necessary health screenings - up to date with eye checks (45% up from 43%), dental check-ups (36% up from 35%), and heart health screenings (31% up from 28%).
30% believe their health is better than their peers, up from 25% in 2023.
Financial concerns are increasingly preventing Kiwi adults from accessing health checks, with 36% citing cost as a barrier (up from 29%).
80% of those with health insurance are committed to health screening checks (vs 72% overall).
More parents feel clear about which screening checks their children need (72% up from 58% in 2023).
More parents believe an annual health check is essential for their children (84% up from 75% in 2023).
More children are staying up to date with common screening tests - hearing checks (54% up from 48%), dental check-ups (66% up from 55%), eye checks (57% up from 50%) and general health exams (59% up from 57%).
Rob Hennin, Chief Executive Officer at nib New Zealand, said
“Proactive health screenings can be lifesaving and it’s really encouraging to see that Kiwi are taking the reins when it comes to their wellbeing. It’s clear to see that accessibility and cost issues continue to be barriers.”
More news:
Jason Gunn announced as new AIA Vitality Ambassador
Gallagher introduce new fundraising initiative, Gallagher Club Kickback
Partners Life go live with “no signature required” for majority of policy administration processes
mySolutions roadshows run across May in Hamilton, Wellington, Christchurch and Auckland
mySolutions webinar 'Exclusive Small Business Group Health' is on 23 April
Financial Advice NZ are holding an Ethics Workshop on 8 May
TAP webinar 'Ready to see TAP in action?' 8 May
Westpac launches a pilot for a basic transactional bank account